Last quarter (Q4 2022), Radiopharm Theranostics Limited's total revenue was AU$―. In Q4, Radiopharm Theranostics Limited's net income was AU$―. See Radiopharm Theranostics Limited’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Jun 22
Total Revenue	AU$ 8.83K
Cost of Revenue	-
Gross Profit	AU$ 8.83K
Operating Expense	AU$ 19.93M
Operating Income	AU$ -19.92M
Net Non Operating Interest Income Expense	AU$ -9.35M
Other Income Expense	AU$ -1.03M
Pretax Income	AU$ -30.29M
Tax Provision	AU$ 44.40K
Earnings From Equity Interest Net Of Tax	-
Net Income Common Stockholders	AU$ -30.34M
Basic EPS	AU$ -0.16
Diluted EPS	AU$ -0.16
Basic Average Shares	AU$ 187.49M
Diluted Average Shares	AU$ 187.49M
Dividend Per Share	-
Total Operating Income As Reported	-
Reported Normalized Basic E P S	-
Reported Normalized Diluted E P S	-
Rent Expense Supplemental	-
Total Expenses	-
Net Income From Continuing And Discontinued Operation	AU$ -30.34M
Normalized Income	AU$ -30.34M
Interest Expense	AU$ 9.35M
EBIT	AU$ -20.94M
EBITDA	AU$ -17.96M

Currency in AUD

Radiopharm Theranostics Limited Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing